Cialis

DRUG4 trials

Sponsors

University of Medicine and Dentistry of New Jersey, Yuhan Corporation, Dongkook Pharmaceutical Co., Ltd., Ottawa Hospital Research Institute

Conditions

Abdominal CancerBenign Prostate HyperplasiaErectile DysfunctionHealthySystemic Sclerosis

Phase 1

Safety and Pharmacokinetic Characteristics of DKF-313

CompletedNCT02352311

Dongkook Pharmaceutical Co., Ltd.Benign Prostate Hyperplasia, Healthy

Start: 2015-01-31End: 2015-06-30Updated: 2021-07-06

Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy

CompletedNCT02998736

Ottawa Hospital Research InstituteAbdominal Cancer

Start: 2017-11-21End: 2022-10-01Updated: 2022-12-28

Phase 2

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

CompletedNCT00707187

University of Medicine and Dentistry of New JerseySystemic Sclerosis

Start: 2001-07-31End: 2002-07-31Updated: 2008-06-30

Safety and Efficacy of YHD1023 in Erectile Dysfunction

CompletedNCT01423370

Yuhan CorporationErectile Dysfunction

Start: 2011-11-30End: 2013-03-31Target: 104Updated: 2014-07-31

Related Papers

The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial

Frontiers in Immunology2019-05-3158 citations